Skip to main content
. 2021 Nov 18;12:6689. doi: 10.1038/s41467-021-26936-y

Fig. 2. Tumor-specific genomic and proteomic events in 46 medulloblastoma tumors.

Fig. 2

The number of a genomic (detected by RNA-seq/WGS) and b proteomic (detected by LC-MS/MS) tumor-specific events are shown for 46 medulloblastoma tumors. The type of tumor-specific genomic events is indicated: SNV/indels (purple), junctions (blue), and gene fusions (orange). The number of identified tumor-specific peptides ranged from 1 to 43 peptides per tumor with a mean of 9 peptides per tumor. c Tile plot depicting the number of tumor-specific peptides identified in medulloblastoma tumors. Black tiles indicate unannotated peptides identified in healthy cerebellum or normal tissues from GTEX. SNVs, fusions, and junctions are shown in purple, orange, and blue respectively. Each gray tile represents a peptide, although some peptides are found in multiple tumors, the vast majority are tumor-specific. Source data are provided as a Source Data file.